High-Dose Fulvestrant for the Treatment of Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer

Tumor Biomarker Changes After Presurgical Treatment of Patients with Breast Cancer with High-Dose Fulvestrant and Anastrozole

Phase II Study of Trastuzumab-DM1 (T-DM1) for Patients with Previously Treated HER2-Positive Metastatic Breast Cancer

NCCTG-N9831: Adjuvant Chemotherapy Alone or with Sequential or Concurrent Addition of 52 Weeks of Trastuzumab in HER2-Positive Breast Cancer

Efficacy of Trastuzumab-Based Regimens in Patients with HER2-Amplified Early-Stage Breast Cancer

Studies on the Efficacy and Safety of Deferasirox for Iron Chelation in Patients with MDS: EPIC and US03

Safety and Efficacy of Combination Therapies with Azacitidine in Elderly Patients with AML or MDS

Phase II Study of Maintenance Treatment with 5-Azacitidine for Patients with MDS or Post-MDS AML

Patterns of Care Survey for Myelodysplastic Syndromes (MDS)

Studies on the Efficacy and Safety of Deferasirox for Iron Chelation in Patients with MDS: EPIC and US03

Lenalidomide Activity in AML with Trisomy 13

Patterns of Care Survey for Acute Myeloid Leukemia (AML)

Five-Day Decitabine Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

CIBMTR Analysis of HCT in Older Patients with AML or MDS